DEBORAH EGGER: Open Payments
NPI 1669407441 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$496 in 11 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $353 · 2025 $496
Food & beverage: $496
| Company | Payments | Amount |
|---|---|---|
| Mirum Pharmaceuticals, Inc. | 1 | $135 |
| GENZYME CORPORATION | 1 | $121 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $100 |
| Solventum Corporation | 3 | $44 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $39 |
| Pacira Pharmaceuticals Incorporated | 1 | $23 |
| Bioventus LLC | 1 | $17 |
| Acera Surgical, Inc. | 1 | $17 |
Products named: Livmarli, DUPIXENT, XIFAXAN, JOURNAVX, Zilretta, EXOGEN ULTRASOUND BONE HEALING SYSTEM, Restrata Wound Matrix, V.A.C.ULTA.
Industry payments across TX — which companies pay providers there.
